Literature DB >> 30840304

Ozone therapy in 65 patients with fibromyalgia: an effective therapy.

U Tirelli1, C Cirrito, M Pavanello, C Piasentin, A Lleshi, R Taibi.   

Abstract

OBJECTIVE: Fibromyalgia is a chronic disorder with a very complex symptomatology. Although generalized severe pain is considered to be the cardinal symptom of the disease, many other associated symptoms, especially non-restorative sleep, chronic fatigue, anxiety, and depressive symptoms also play a relevant role in the degree of disability characteristic of the disease. Ozone therapy, which is used to treat a wide range of diseases and seems to be particularly useful in the treatment of many chronic diseases, is thought to act by exerting a mild, transient, and controlled oxidative stress that promotes an up-regulation of the antioxidant system and a modulation of the immune system. According to these mechanisms of action, it was hypothesized that ozone therapy could be useful in fibromyalgia management, where the employed therapies are very often ineffective. PATIENTS AND METHODS: Sixty-five patients with fibromyalgia, according to the definition of the American College of Rheumatology (Arthritis Rheum 1990; 33: 160-172), were treated at the MEDE Clinic (Sacile, Pordenone, Italy) from February 2016 to October 2018. Females were 55 and males were 10; age ranged from 30 to 72 years, and the time from fibromyalgia diagnosis ranged from 0.5 to 33 years. Treatment was made by autohemotransfusion in 55 patients and by ozone rectal insufflations in 10 patients, according to SIOOT (Scientific Society of Oxygen Ozone Therapy) protocols, twice a week for one month and then twice a month as maintenance therapy.
RESULTS: We found a significative improvement (>50% of symptoms) in 45 patients (70%). No patient reported important side effects. In conclusion, at our knowledge, this is the largest study of patients with fibromyalgia treated with ozone therapy reported in the literature and it demonstrates that the ozone therapy is an effective treatment for fibromyalgia patients without significant side effects.
CONCLUSIONS: At the moment, ozone therapy seems a treatment that, also because without any side effect, is possible to be proposed to patients with fibromyalgia that are not obtaining adequate results from other available treatments and it can be considered as complementary/integrative medicine.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30840304     DOI: 10.26355/eurrev_201902_17141

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  Relationship of ozone application and time in rats with hypoxic-ischemic brain injury.

Authors:  B Resitoglu; C Yalcın; M Komur; A Polat; S Erdogan; H Beydagi
Journal:  Hippokratia       Date:  2021 Apr-Jun       Impact factor: 0.522

Review 2.  Oxygen-Ozone Therapy in the Rehabilitation Field: State of the Art on Mechanisms of Action, Safety and Effectiveness in Patients with Musculoskeletal Disorders.

Authors:  Alessandro de Sire; Francesco Agostini; Lorenzo Lippi; Massimiliano Mangone; Simone Marchese; Carlo Cisari; Andrea Bernetti; Marco Invernizzi
Journal:  Biomolecules       Date:  2021-02-26

Review 3.  Expert consensus on the diagnosis and treatment of myofascial pain syndrome.

Authors:  Qi-Wang Cao; Bao-Gan Peng; Lin Wang; You-Qing Huang; Dong-Lin Jia; Hao Jiang; Yan Lv; Xian-Guo Liu; Rong-Guo Liu; Ying Li; Tao Song; Wen Shen; Ling-Zhi Yu; Yong-Jun Zheng; Yan-Qing Liu; Dong Huang
Journal:  World J Clin Cases       Date:  2021-03-26       Impact factor: 1.337

4.  Intraperitoneal ozone injection prevents REM sleep deprivation - induced spatial learning and memory deficits by suppressing the expression of Sema3A in the hippocampus in rats.

Authors:  Yi-Ning Yan; John P Williams; Kun Niu; Wen-Hao Zhang; Jian-Feng Zhang; Le Shi; Jian-Xiong An
Journal:  Iran J Basic Med Sci       Date:  2022-08       Impact factor: 2.532

5.  The Relationship between Ozone and Human Blood in the Course of a Well-Controlled, Mild, and Transitory Oxidative Eustress.

Authors:  Gerardo Tricarico; Valter Travagli
Journal:  Antioxidants (Basel)       Date:  2021-12-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.